CELLULAR HEALTH RESEARCH
PT-141
10 mg
A Novel Melanocortin Receptor Agonist for Sexual Wellness Research.
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide analog of alpha-MSH that activates melanocortin receptors. It has been studied in human clinical research for its potential role in sexual desire and arousal. This product is intended for research purposes only.
A Healthier Tomorrow
PT-141
10 mg
$85.00 — or Original price was: $85.00.$76.50Current price is: $76.50. / month
Ships within 1-2 Business Days
Subscribe monthly and save 10%
- Ship to Canada,USA & Mexico
- Secure Checkout
- Add to wishlist
PREMIUM QUALITY:
Pharmaceutical-grade
INDEPENDENT TESTING:
Quality verification
BATCH TRANSPARENCY:
Product information
GLOBAL ACCESS:
Canada, USA & Mexico
SUPPORTING A HEALTHIER YOU
Real Benefits for Real Life.
PT-141 (bremelanotide) has been studied in human clinical research for its potential to support sexual desire and arousal. By targeting melanocortin receptors in the central nervous system, it may support the sexual response and overall sexual wellness.
- May help increase sexual desire and arousal (research)
- Supports healthy sexual function (research)
- Acts on central nervous system pathways (research)
- Non-hormonal mechanism of action
- Studied in human clinical trials
KEY AREAS OF HUMAN
KEY AREAS OF HUMAN
The Science
Evidence & Mechanism
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide analog of alpha-MSH that activates melanocortin receptors, including MC1R, MC3R and MC4R, in the central nervous system. It is thought to influence sexual response pathways in the brain. The precise mechanism by which bremelanotide improves sexual desire in humans remains incompletely understood, and human clinical evidence is limited, with mixed results.
Product Information
| Product Name | PT-141 |
| Common Name | Bremelanotide |
| Strength | 10 mg |
| Molecular Weight | ~980.1 Da |
| Product Format | Lyophilized powder |
| Purity | > 99% (HPLC) |
| Storage | Store refrigerated (2°C–8°C). Protect from light and moisture. |
| Intended Use | Research use only. Not approved for human use. |
Why Choose Nextgen
- Premium quality research products
- Independent laboratory testing
- Batch transparency
- Consistent quality standards
- Milligram App integration
- Dedicated customer support
FREQUENTLY ASKED QUESTIONS
Your Questions, Answered.
Find quick answers to common questions about this Product.
PT-141, also called bremelanotide, has been tested in two randomized phase 3 trials involving premenopausal women with hypoactive sexual desire disorder. The clinical preparation improved desire scores and reduced related distress compared with placebo. These are findings for a diagnosed condition and study population, rather than a promise of stronger sexual performance for everyone.
The bremelanotide studies reported nausea, flushing and headache among common adverse effects. Separate research and prescribing information also address blood-pressure effects. Improvements in desire scores do not mean that everyone benefits or tolerates treatment. Findings for the studied medicine do not establish the clinical suitability of a supplier’s research vial.
Melanotan II shares a melanocortin research background but is a different molecule. Kisspeptin-10 mainly has human evidence on reproductive hormone signalling. Neither body of research establishes equivalent sexual-health benefits. Conversely, PT-141 trial results should not be used to validate tanning claims or general testosterone and fertility claims for these related-reading compounds.